Asthma Flashcards
Pathophysiology
Symptoms of asthma result from a combination of inflammation and bronchoconstriction, so treatment must address both components
Asthma
Chronic inflammatory disorder of the airway; characteristic signs and symptoms: sense of breathlessness, tightening of the chest, wheezing, dyspnea, cough
-Cause: immune mediated airway inflammation
Two main pharmacologic classes
Anti-inflammatory agents: glucocorticoids (prednisone); bronchodilators: beta2 agonists (albuterol)
Inhalation drug therapy
Three obvious advantages: therapeutic effects are enhanced, systemic effects are minimized, relief of acute attacks is rapid
-Three types: metered-dose inhalers (MDIs), dry-powder inhalers (DPIs), nebulizers
Anti-inflammatory drugs
Foundation of asthma therapy, taken daily for long-term control, principal anti-inflammatory drugs are the glucocorticoids
Glucocorticoids
Include budesonide and fluticasone, usually administered by inhalation, but IV and oral are also options; mechanism of action: suppress inflammation; adverse effects: minor when taken acutely, can be severe when used long-term (adrenal suppression, osteoporosis, hyperglycemia)
Leukotriene Modifiers
Suppress effects of leukotrienes, less effective than inhaled glucocorticoids; available agents: zileuton (Zyflo), zarfirlukast (Accolate), montelukast (Singulair)
Cromolyn
Used for prophylaxis, not for quick relief; supresses inflammation, not a bronchodilator
-Route: inhalation (nebulizer, MDI); adverse effects: safest of all antiasthma medications, cough, bronchospasm
Bronchodilators
Provide symptomatic relief but do not alter the underlying disease process (inflammation); in almost all cases, patient taking a bronchodilator should be taking a glucocorticoid for long-term suppression of inflammation
-Principal bronchodilators are the beta2-adrengergic agonists
Beta2-Adrenergic Agonists
Include albuterol, salmeterol, terbutaline; most effective drugs for relief of acute bronchospasm and prevention of exercise-induced bronchospasm
-Use in asthma: both quick relief and long-term control
Beta2-Adrenergic Agonists: adverse effects
Inhaled preparations
-systemic effects: tachycardia, angina, and tremor
Oral preparations
-excessive dosage: angina pectoris, tachydysrhythmias; tremor
Beta2-Adrenergic Agonists: Mechanism of action
Activate beta2 receptors in smooth muscle of lung, promoting bronchodilation and thereby relieving bronchospasm; also suppress histamine release in lung and increase ciliary motility
Bronchodilators: methylxanthines
Theophylline: benefits derive primarily from bronchodilation, narrow therapeutic index, plasma level 10 to 20 mcg/mL, toxicity is related to theophylline levels
-other methylxanthines: aminophylline, dyphylline
Glucocorticoid/LABA Combinations
Available combinations: fluticason/salmeterol (Advair), budesonide/formoterol (Symbicort); indicated for long term maintenance in adults and children, not recommended for initial therapy
Tests of lung function
Forced expiratory volume in 1 second (FEV1), forced vital capacity (FVC), peak expiratory flow (PEF)